Reuters logo
BRIEF-Staidson Beijing BioPharmaceuticals sees Q1 to Q3 of FY 2017 net profit up 5 pct to 20 pct
October 13, 2017 / 3:53 AM / 2 months ago

BRIEF-Staidson Beijing BioPharmaceuticals sees Q1 to Q3 of FY 2017 net profit up 5 pct to 20 pct

Oct 13(Reuters) - Staidson Beijing BioPharmaceuticals Co Ltd

* Sees Q1 to Q3 of FY 2017 net profit to increase by 5 percent to 20 percent, or to be about 213.2 million yuan to about 243.6 million yuan

* Says Q1 to Q3 of FY 2016 net profit was 203 million yuan

Source text in Chinese: goo.gl/NngW1Q

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below